Lauren Santye, Assistant Editor

Subcapsular sinus macrophages may influence cancer mortality.

Researchers gain greater understanding of genetic and biological basis of diseases such as Alzheimer’s disease, cancer, diabetes, and rheumatoid arthritis.

As melatonin levels rise, beta cells are prompted to release less insulin.

Patients can receive real-time personalized feedback, while providers receive alerts when treatment thresholds are crossed or changes are made.

Active surveillance seems to be safe in patients who are low risk, and certain patients at intermediate risk.

Top news from across the health care landscape.

HCV-related death reached 19,596 in 2014 as cases of new infections have more than doubled from 2010 to 2014.

Testosterone therapy may actually inhibit the growth of aggressive prostate cancer.

Grant E. Knowles, vice president of business development at Ardon Health, discusses how biosimilars may impact the high cost of specialty drugs.

Study evaluates survival in older patients with soft tissue sarcoma.

Top news of the day from across the health care landscape.

Marc O'Connor, chief operating officer of Curant Health, discusses how the transition to value-based care can be optimized for specialty stakeholders.

Gregory R. Morris, chief commercial officer at VirMedica, discusses how eAccess can benefit patients and providers.

Deborah Michaelson, MS, RPh, discusses the elements of an ideal specialty pharmacy therapy management program.

Coffee consumption with high fat diet found to improve non-alcoholic fatty liver disease.

Personalized cancer treatments need to account for conditions such as heart or lung diseases.

New research shines light on cancer drug resistance.

Top news of the day from across the health care landscape.

Animal model of malignant plasma-cell disease may accelerate new treatments for multiple myeloma.

MS patients who use cognitive remediation training program showed improvement in neuropsychological tests.

Paper device offers on-the-go inexpensive diagnosis of hepatitis C and HIV.

Numerical simulations show the long-term success of immunotherapy is dependent on random fluctuations.

Cancer tumors are unable to grow larger than 2 millimeters unless angiogenesis is present.

Top news of the day from across the health care landscape.

Immune response that attacks tumors may significantly improve progression-free survival.

Potent broadly neutralizing antibody binds to HIV and causes a strong immune response.

Top news of the day from across the health care landscape.

Baricitinib is a Janus-kinase inhibitor that interferes with intracellular enzymes in rheumatoid arthritis.

Rapamycin may effectively treat patients with venous malformations.

ACC is a hard-to-treat glandular cancer that is both rare and lethal.